SightfileU.S. market data from official filings

Companies › NVNO

ENVVENO MEDICAL CORPORATION (NVNO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001661053 · EDGAR filings · Updated 2026-07-14

ENVVENO MEDICAL CORPORATION (NVNO) has reported institutional ownership of 15.3%, with 17 institutional managers holding positions valued at $1.02M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
15.3%
Institutional managers
17
Reported 13F value
$1.02M
Insider activity
3 trans.
−$7.44K net selling
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENVVENO MEDICAL CORPORATION has 17 institutional holders and institutional ownership of 15.3%.

Insider activity

Insiders reported 3 transactions (0 buys, 3 sells) across 3 reporting insiders, with a net reported value of −$7.44K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-10-10 (recurring since 2020-03-25) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2020-11-17 (recurring since 2020-03-18) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Mannatech Inc (MTEX) · CHARMING MEDICAL LTD (MCTA) · ALLARITY THERAPEUTICS INC (ALLR) · BioNano Genomics Inc (BNGO) · Icecure Medical Ltd (ICCM) · JYONG BIOTECH LTD (MENS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.